Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery

NCT04025164 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4052

Last updated 2019-07-18

No results posted yet for this study

Summary

The study was designed to investigate whether hypofractionated radiotherapy(HF-RT) is noninferior to conventionally fractionated radiotherapy (CF-RT) in terms of tumor loco-regional control for patients after breast conserving surgery

Conditions

Interventions

RADIATION

Hypofractionated Radiotherapy

daily fractions, 2.66 Gy/3.2 Gy per fraction to whole breast/tumor bed, five fractions per week

RADIATION

Conventional fractionated Radiotherapy

daily fractions, 2 Gy per fraction, five fractions per week

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Xiaoli Yu, MD, PhD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2023-06-30
Completion
2028-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04025164 on ClinicalTrials.gov